Invitrix Therapeutics

Invitrx Therapeutics is a private regenerative medicine and biotechnology company focused on adult stem cell culture and engineering. Founded in 2003 by Habib Torfi, the company has developed cell- and biologics-based products intended for wound healing, burns, diabetic ulcers, ocular surface and other ophthalmic conditions, as well as aesthetic and reconstructive applications. Publicly available descriptions also highlight cytokine and growth factor technologies derived from its stem cell work and the ReLuma skin, hair, and lash product line. The company appears to operate primarily as a clinical-stage, platform-oriented regenerative medicine business rather than a conventional late-stage therapeutics developer. Available public sources do not provide a clearly disclosed modern clinical pipeline with named assets and trial stages.